# Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and Thrombosis

> **NCT00422396** · NA · COMPLETED · sponsor: **University of Michigan** · enrollment: 60 (—)

## Conditions studied

- Hypertriglyceridemia With the Metabolic Syndrome

## Interventions

- **DRUG:** Fenofibrate (drug)

## Key facts

- **NCT ID:** NCT00422396
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-01
- **Primary completion:** 2002-04
- **Final completion:** 2002-04
- **Target enrollment:** 60 (—)
- **Last updated:** 2017-02-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00422396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00422396, "Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and Thrombosis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00422396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*